vs
Niagen Bioscience, Inc.（NAGE）与优莎娜（USNA）财务数据对比。点击上方公司名可切换其他公司
优莎娜的季度营收约是Niagen Bioscience, Inc.的6.3倍（$213.7M vs $33.8M）。Niagen Bioscience, Inc.净利率更高（12.2% vs -3.1%，领先15.3%）。Niagen Bioscience, Inc.同比增速更快（16.2% vs 6.7%）。过去两年Niagen Bioscience, Inc.的营收复合增速更高（23.6% vs -1.7%）
Niagen Bioscience（原名为ChromaDex）是一家成立于1999年，总部位于加利福尼亚州洛杉矶的生物科技公司。公司业务涵盖标准品、膳食补充剂以及原料技术开发多个领域，目前在纳斯达克挂牌上市。
USANA是总部位于美国犹他州盐湖城的多层次营销企业，以 revenue 计位列2021年全球第14大直销企业。公司主打营养产品、膳食补充剂与护肤产品，大部分产品在盐湖城自有工厂生产，产品通过独立经销商网络销往全球24个国家。
NAGE vs USNA — 直观对比
营收规模更大
USNA
是对方的6.3倍
$33.8M
营收增速更快
NAGE
高出9.5%
6.7%
净利率更高
NAGE
高出15.3%
-3.1%
两年增速更快
NAGE
近两年复合增速
-1.7%
损益表 — Q4 2025 vs Q3 2026
| 指标 | | |
|---|---|---|
| 营收 | $33.8M | $213.7M |
| 净利润 | $4.1M | $-6.5M |
| 毛利率 | 64.1% | 77.2% |
| 营业利润率 | 12.1% | 0.6% |
| 净利率 | 12.2% | -3.1% |
| 营收同比 | 16.2% | 6.7% |
| 净利润同比 | -42.4% | -161.5% |
| 每股收益（稀释后） | $0.05 | $-0.36 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NAGEUSNA
| Q4 25 | $33.8M | — | ||
| Q3 25 | $34.0M | $213.7M | ||
| Q2 25 | $31.1M | $235.8M | ||
| Q1 25 | $30.5M | $249.5M | ||
| Q4 24 | $29.1M | $213.6M | ||
| Q3 24 | $25.6M | $200.2M | ||
| Q2 24 | $22.7M | $212.9M | ||
| Q1 24 | $22.2M | $227.8M |
净利润NAGEUSNA
| Q4 25 | $4.1M | — | ||
| Q3 25 | $4.6M | $-6.5M | ||
| Q2 25 | $3.6M | $9.7M | ||
| Q1 25 | $5.1M | $9.4M | ||
| Q4 24 | $7.2M | $4.5M | ||
| Q3 24 | $1.9M | $10.6M | ||
| Q2 24 | $-15.0K | $10.4M | ||
| Q1 24 | $-492.0K | $16.5M |
毛利率NAGEUSNA
| Q4 25 | 64.1% | — | ||
| Q3 25 | 64.5% | 77.2% | ||
| Q2 25 | 65.0% | 78.7% | ||
| Q1 25 | 63.4% | 79.0% | ||
| Q4 24 | 62.5% | 82.0% | ||
| Q3 24 | 63.5% | 80.4% | ||
| Q2 24 | 60.2% | 81.1% | ||
| Q1 24 | 60.7% | 81.1% |
营业利润率NAGEUSNA
| Q4 25 | 12.1% | — | ||
| Q3 25 | 12.5% | 0.6% | ||
| Q2 25 | 10.2% | 7.1% | ||
| Q1 25 | 15.7% | 6.3% | ||
| Q4 24 | 24.4% | 3.8% | ||
| Q3 24 | 6.3% | 7.8% | ||
| Q2 24 | -1.1% | 8.4% | ||
| Q1 24 | -3.3% | 10.8% |
净利率NAGEUSNA
| Q4 25 | 12.2% | — | ||
| Q3 25 | 13.5% | -3.1% | ||
| Q2 25 | 11.6% | 4.1% | ||
| Q1 25 | 16.6% | 3.8% | ||
| Q4 24 | 24.6% | 2.1% | ||
| Q3 24 | 7.3% | 5.3% | ||
| Q2 24 | -0.1% | 4.9% | ||
| Q1 24 | -2.2% | 7.3% |
每股收益（稀释后）NAGEUSNA
| Q4 25 | $0.05 | — | ||
| Q3 25 | $0.05 | $-0.36 | ||
| Q2 25 | $0.04 | $0.52 | ||
| Q1 25 | $0.06 | $0.49 | ||
| Q4 24 | $0.10 | $0.23 | ||
| Q3 24 | $0.02 | $0.56 | ||
| Q2 24 | $0.00 | $0.54 | ||
| Q1 24 | $-0.01 | $0.86 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $145.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $76.5M | $528.1M |
| 总资产 | $106.4M | $726.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资NAGEUSNA
| Q4 25 | — | — | ||
| Q3 25 | $64.1M | $145.3M | ||
| Q2 25 | $60.3M | $151.3M | ||
| Q1 25 | $55.5M | $179.6M | ||
| Q4 24 | $44.5M | $181.8M | ||
| Q3 24 | $32.2M | $364.9M | ||
| Q2 24 | $27.7M | $332.4M | ||
| Q1 24 | $27.4M | $328.3M |
股东权益NAGEUSNA
| Q4 25 | $76.5M | — | ||
| Q3 25 | $70.7M | $528.1M | ||
| Q2 25 | $64.2M | $531.1M | ||
| Q1 25 | $55.3M | $529.8M | ||
| Q4 24 | $46.1M | $532.1M | ||
| Q3 24 | $34.4M | $533.1M | ||
| Q2 24 | $30.7M | $512.2M | ||
| Q1 24 | $29.0M | $500.0M |
总资产NAGEUSNA
| Q4 25 | $106.4M | — | ||
| Q3 25 | $98.1M | $726.6M | ||
| Q2 25 | $91.5M | $734.5M | ||
| Q1 25 | $81.3M | $746.6M | ||
| Q4 24 | $68.3M | $748.2M | ||
| Q3 24 | $56.5M | $671.3M | ||
| Q2 24 | $54.0M | $631.4M | ||
| Q1 24 | $54.1M | $629.3M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $679.0K | $-2.0M |
| 自由现金流经营现金流 - 资本支出 | — | $-5.2M |
| 自由现金流率自由现金流/营收 | — | -2.4% |
| 资本支出强度资本支出/营收 | — | 1.5% |
| 现金转化率经营现金流/净利润 | 0.16× | — |
| 过去12个月自由现金流最近4个季度 | — | $18.7M |
8季度趋势，按日历期对齐
经营现金流NAGEUSNA
| Q4 25 | $679.0K | — | ||
| Q3 25 | $3.7M | $-2.0M | ||
| Q2 25 | $1.3M | $12.2M | ||
| Q1 25 | $7.9M | $15.5M | ||
| Q4 24 | $8.6M | $5.8M | ||
| Q3 24 | $3.5M | $29.5M | ||
| Q2 24 | $-264.0K | $8.0M | ||
| Q1 24 | $295.0K | $17.7M |
自由现金流NAGEUSNA
| Q4 25 | — | — | ||
| Q3 25 | — | $-5.2M | ||
| Q2 25 | — | $7.2M | ||
| Q1 25 | — | $12.7M | ||
| Q4 24 | — | $4.0M | ||
| Q3 24 | — | $27.1M | ||
| Q2 24 | — | $5.3M | ||
| Q1 24 | — | $14.5M |
自由现金流率NAGEUSNA
| Q4 25 | — | — | ||
| Q3 25 | — | -2.4% | ||
| Q2 25 | — | 3.0% | ||
| Q1 25 | — | 5.1% | ||
| Q4 24 | — | 1.9% | ||
| Q3 24 | — | 13.6% | ||
| Q2 24 | — | 2.5% | ||
| Q1 24 | — | 6.4% |
资本支出强度NAGEUSNA
| Q4 25 | — | — | ||
| Q3 25 | — | 1.5% | ||
| Q2 25 | — | 2.1% | ||
| Q1 25 | — | 1.1% | ||
| Q4 24 | — | 0.8% | ||
| Q3 24 | — | 1.2% | ||
| Q2 24 | — | 1.3% | ||
| Q1 24 | — | 1.4% |
现金转化率NAGEUSNA
| Q4 25 | 0.16× | — | ||
| Q3 25 | 0.81× | — | ||
| Q2 25 | 0.35× | 1.27× | ||
| Q1 25 | 1.56× | 1.65× | ||
| Q4 24 | 1.20× | 1.29× | ||
| Q3 24 | 1.86× | 2.78× | ||
| Q2 24 | — | 0.77× | ||
| Q1 24 | — | 1.07× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NAGE
| TRUNIAGEN Consumer Product | $27.5M | 81% |
| Ingredients Segment | $5.7M | 17% |
| Other | $694.0K | 2% |
USNA
| Direct Selling | $175.8M | 82% |
| Hiya | $30.8M | 14% |
| All Other | $7.0M | 3% |
